Free same-day US shipping on orders over $150.00 · bulk pricing on 2+ vials
For research use only. Not for human or animal consumption.
Compound Monograph

GHK-Cu (Copper Peptide): Mechanism

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, one of the most extensively studied copper-binding peptides in the biochemical literature. This monograph describes its coordination chemistry, its proposed molecular mechanisms, and the extracellular-matrix and gene-expression endpoints that in-vitro and animal-model research investigates. All content is for laboratory research use only.

Molecular class and composition

GHK is a tripeptide with the sequence Gly-His-Lys (glycyl-L-histidyl-L-lysine), a small human peptide originally isolated from plasma. In its biologically studied form it is complexed with a divalent copper ion, Cu(II), to form GHK-Cu — a copper-binding tripeptide complex rather than a simple free peptide.

The apo-peptide GHK has a molecular formula of C14H24N6O4 (molar mass ~340.4 g/mol). The copper complex adds a coordinated Cu(II) center; the peptide is best characterized as a metal-peptide coordination complex whose properties depend on the copper it carries.

Copper coordination chemistry

The defining chemical feature of GHK-Cu is its high, selective affinity for copper(II). Coordination is provided principally by the imidazole nitrogen of the histidine residue, the alpha-amino terminus of glycine, and the deprotonated amide nitrogen between glycine and histidine, with the lysine side chain contributing to overall stability. This arrangement forms a square-planar Cu(II) coordination geometry characteristic of the complex.

This coordination is why the literature treats GHK-Cu as a physiological copper carrier and exchanger: the complex is studied as a vehicle that can present or exchange copper with other biomolecules, and much of its proposed activity is discussed in terms of copper delivery and redox-relevant coordination rather than the bare peptide acting alone.

What the literature investigates

Research on GHK-Cu focuses heavily on extracellular-matrix biology in cell-culture and animal models. Reported endpoints include modulation of the expression of matrix components such as collagens and glycosaminoglycans, and of matrix-remodeling enzymes including matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs).

A separate line of investigation uses large-scale gene-expression (transcriptomic) profiling, which has reported that GHK exposure shifts the expression of a broad set of genes in model systems. The literature frames these observations as data on tissue-remodeling and antioxidant-related pathways in vitro — mechanistic and model-level findings, not demonstrations of any consumer or clinical outcome.

  • ECM component expression (collagens, glycosaminoglycans) in culture models.
  • Matrix-remodeling enzymes (MMPs) and their inhibitors (TIMPs).
  • Copper-dependent redox and antioxidant-associated pathways.
  • Broad transcriptomic modulation reported in gene-expression studies.

Why the copper matters mechanistically

Because copper is a cofactor for enzymes involved in matrix cross-linking (such as lysyl oxidase) and in redox handling (such as superoxide dismutase), the copper carried by GHK-Cu is central to how the literature reasons about its mechanism. Studies frequently distinguish effects attributable to the intact copper complex from those of the copper-free peptide, underscoring that GHK and GHK-Cu should be treated as distinct research entities.

Laboratory handling and verification

GHK-Cu is typically supplied as a lyophilized powder with a characteristic blue coloration from the coordinated copper. Handling follows standard peptide practice with attention to the metal center's sensitivity to pH and to competing chelators in buffers.

Each Kairo Labs lot is verified to the lot with a Certificate of Analysis confirming identity and purity, so the copper-complexed tripeptide is characterized before use in research.

Frequently asked
What is the difference between GHK and GHK-Cu?

GHK is the free tripeptide Gly-His-Lys. GHK-Cu is that peptide complexed with a copper(II) ion. Because copper is central to its proposed mechanism, the literature treats the two as distinct research entities.

How does GHK-Cu bind copper?

Copper(II) is coordinated primarily by the histidine imidazole nitrogen, the N-terminal glycine amino group, and the deprotonated amide nitrogen between glycine and histidine, forming a square-planar complex stabilized by the lysine residue.

What does research on GHK-Cu investigate?

In vitro and animal-model studies examine extracellular-matrix component expression, matrix-remodeling enzymes (MMPs/TIMPs), copper-dependent redox pathways, and broad gene-expression changes — all at the mechanistic and model level.

Why does the copper matter to the mechanism?

Copper is a cofactor for matrix-crosslinking and redox enzymes, so studies attribute much of GHK-Cu's proposed activity to copper coordination and exchange rather than the peptide backbone alone.

How is the complex verified?

Each Kairo Labs lot ships with a Certificate of Analysis verified to the lot, confirming identity and purity of the copper-complexed tripeptide before research use.

Research Use Only. All products and information referenced by Kairo Labs are intended strictly for laboratory research and educational purposes. They are not for human or animal consumption, and not for diagnostic, therapeutic, or clinical use. This content describes mechanisms, molecular properties, and handling as studied in the scientific literature; it is educational, not medical advice, and not a recommendation to use any compound in humans or animals. Researchers are responsible for handling all materials in accordance with applicable laws, regulations, and institutional safety protocols.